• 1
    Inohara, N. and Nunez, G., NODs: intracellular proteins involved in inflammation and apoptosis. Nat. Rev. Immunol. 2003 3: 371382.
  • 2
    Ting, J. P. and Davis, B. K., CATERPILLER: a novel gene family important in immunity, cell death, and diseases. Annu. Rev. Immunol. 2005 23: 387414.
  • 3
    Girardin, S. E., Boneca, I. G., Viala, J., Chamaillard, M., Labigne, A., Thomas, G., Philpott, D. J. and Sansonetti, P. J., Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J. Biol. Chem. 2003 278: 88698872.
  • 4
    Hugot, J. P., Chamaillard, M., Zouali, H., Lesage, S., Cezard, J. P., Belaiche, J., Almer, S. et al., Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001 411: 599603.
  • 5
    Ogura, Y., Bonen, D. K., Inohara, N., Nicolae, D. L., Chen, F. F., Ramos, R., Britton, H. et al., A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001 411: 603606.
  • 6
    Eckmann, L. and Karin, M., NOD2 and Crohn's disease: loss or gain of function? Immunity 2005 22: 661667.
  • 7
    Netea, M. G., Ferwerda, G., de Jong, D. J., Girardin, S. E., Kullberg, B. J. and Van der Meer, J. W., NOD2 3020insC mutation and the pathogenesis of Crohn's disease: impaired IL-1beta production points to a loss-of-function phenotype. Neth. J. Med. 2005 63: 305308.
  • 8
    Watanabe, T., Kitani, A. and Strober, W., NOD2 regulation of Toll-like receptor responses and the pathogenesis of Crohn's disease. Gut 2005 54: 15151518.
  • 9
    van Heel, D. A., Ghosh, S., Butler, M., Hunt, K. A., Lundberg, A. M., Ahmad, T., McGovern, D. P. et al., Muramyl dipeptide and toll-like receptor sensitivity in NOD2-associated Crohn's disease. Lancet 2005 365: 17941796.
  • 10
    Dinarello, C. A., Interleukin-1 beta, interleukin-18, and the interleukin-1 beta converting enzyme. Ann. NY Acad. Sci. 1998 856: 111.
  • 11
    Mackenzie, A., Wilson, H. L., Kiss-Toth, E., Dower, S. K., North, R. A. and Surprenant, A., Rapid secretion of interleukin-1beta by microvesicle shedding. Immunity 2001 15: 825835.
  • 12
    Martinon, F., Agostini, L., Meylan, E. and Tschopp, J., Identification of bacterial muramyl dipeptide as activator of the NALP3/cryopyrin inflammasome. Curr. Biol. 2004 14: 19291934.
  • 13
    Agostini, L., Martinon, F., Burns, K., McDermott, M. F., Hawkins, P. N. and Tschopp, J., NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder. Immunity 2004 20: 319325.
  • 14
    Faustin, B., Lartigue, L., Bruey, J. M., Luciano, F., Sergienko, E., Bailly-Maitre, B., Volkmann, N. et al., Reconstituted NALP1 inflammasome reveals two-step mechanism of caspase-1 activation. Mol. Cell 2007 25: 713724.
  • 15
    Kobayashi, K., Inohara, N., Hernandez, L. D., Galan, J. E., Nunez, G., Janeway, C. A., Medzhitov, R. and Flavell, R. A., RICK/Rip2/CARDIAK mediates signalling for receptors of the innate and adaptive immune systems. Nature 2002 416: 194199.
  • 16
    Inohara, N., Koseki, T., Lin, J., del Peso, L., Lucas, P. C., Chen, F. F., Ogura, Y. and Nunez, G., An induced proximity model for NF-kappa B activation in the Nod1/RICK and RIP signaling pathways. J. Biol. Chem. 2000 275: 2782327831.
  • 17
    Abbott, D. W., Wilkins, A., Asara, J. M. and Cantley, L. C., The Crohn's disease protein, NOD2, requires RIP2 in order to induce ubiquitinylation of a novel site on NEMO. Curr .Biol. 2004 14: 22172227.
  • 18
    Thome, M., Hofmann, K., Burns, K., Martinon, F., Bodmer, J. L., Mattmann, C. and Tschopp, J., Identification of CARDIAK, a RIP-like kinase that associates with caspase-1. Curr. Biol. 1998 8: 885888.
  • 19
    Yoo, N. J., Park, W. S., Kim, S. Y., Reed, J. C., Son, S. G., Lee, J. Y. and Lee, S. H., Nod1, a CARD protein, enhances pro-interleukin-1beta processing through the interaction with pro-caspase-1. Biochem. Biophys. Res. Commun. 2002 299: 652658.
  • 20
    Netea, M. G., Ferwerda, G., de Jong, D. J., Jansen, T., Jacobs, L., Kramer, M., Naber, T. H. et al., Nucleotide-binding oligomerization domain-2 modulates specific TLR pathways for the induction of cytokine release. J. Immunol. 2005 174: 65186523.
  • 21
    Schindler, R., Ghezzi, P. and Dinarello, C. A., IL-1 induces IL-1. IV. IFN-gamma suppresses IL-1 but not lipopolysaccharide-induced transcription of IL-1. J. Immunol. 1990 144: 22162222.
  • 22
    Dinarello, C. A., Biologic basis for interleukin-1 in disease. Blood 1996 87: 20952147.
  • 23
    Bodar, E. J., van der Hilst, J. C., Drenth, J. P., Van der Meer, J. W. and Simon, A., Effect of etanercept and anakinra on inflammatory attacks in the hyper-IgD syndrome: introducing a vaccination provocation model. Neth. J. Med. 2005 63: 260264.
  • 24
    Lovell, D. J., Bowyer, S. L. and Solinger, A. M., Interleukin-1 blockade by anakinra improves clinical symptoms in patients with neonatal-onset multisystem inflammatory disease. Arthritis Rheum. 2005 52: 12831286.
  • 25
    Hawkins, P. N., Lachmann, H. J. and McDermott, M. F., Interleukin-1-receptor antagonist in the Muckle-Wells syndrome. N. Engl. J. Med. 2003 348: 25832584.
  • 26
    Hoffman, H. M., Rosengren, S., Boyle, D. L., Cho, J. Y., Nayar, J., Mueller, J. L. Anderson, J. P. et al., Prevention of cold-associated acute inflammation in familial cold autoinflammatory syndrome by interleukin-1 receptor antagonist. Lancet 2004 364: 17791785.
  • 27
    Simon, A., Bodar, E. J., van der Hilst, J. C., Van der Meer, J. W., Fiselier, T. J., Cuppen, M. P. and Drenth, J. P., Beneficial response to interleukin 1 receptor antagonist in traps. Am. J. Med. 2004 117: 208210.
  • 28
    Joshi, V. D., Kalvakolanu, D. V., Hebel, J. R., Hasday, J. D. and Cross, A. S., Role of caspase 1 in murine antibacterial host defenses and lethal endotoxemia. Infect. Immun. 2002 70: 68966903.
  • 29
    Boatright, K. M. and Salvesen, G. S., Caspase activation. Biochem. Soc. Symp. 2003 233242.
  • 30
    Martinon, F. and Tschopp, J., Inflammatory caspases: linking an intracellular innate immune system to autoinflammatory diseases. Cell 2004 117: 561574.
  • 31
    Pan, Q., Mathison, J., Fearns, C., Kravchenko, V. V., Correia, J. D., Hoffman, H. M., Kobayashi, K. S. et al., MDP-induced interleukin-1{beta} processing requires Nod2 and CIAS1/NALP3. J. Leukoc. Biol. 2007
  • 32
    Duncan, J. A., Bergstralh, D. T., Wang, Y., Willingham, S. B., Ye, Z., Zimmermann, A. G. and Ting, J. P., Cryopyrin/NALP3 binds ATP/dATP, is an ATPase, and requires ATP binding to mediate inflammatory signaling. Proc. Natl Acad. Sci. USA 2007 104: 80418046.
  • 33
    Mariathasan, S., Weiss, D. S., Newton, K., McBride, J., O'Rourke, K., Roose-Girma, M., Lee, W. P. et al., Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 2006 440: 228232.
  • 34
    Kanneganti, T. D., Ozoren, N., Body-Malapel, M., Amer, A., Park, J. H., Franchi, L., Whitfield, J. et al., Bacterial RNA and small antiviral compounds activate caspase-1 through cryopyrin/Nalp3. Nature 2006 440: 233236.
  • 35
    Maeda, S., Hsu, L. C., Liu, H., Bankston, L. A., Iimura, M., Kagnoff, M. F., Eckmann, L. and Karin, M., Nod2 mutation in Crohn's disease potentiates NF-kappaB activity and IL-1beta processing. Science 2005 307: 734738.
  • 36
    Uehara, A., Yang, S., Fujimoto, Y., Fukase, K., Kusumoto, S., Shibata, K., Sugawara, S. and Takada, H., Muramyldipeptide and diaminopimelic acid-containing desmuramylpeptides in combination with chemically synthesized Toll-like receptor agonists synergistically induced production of interleukin-8 in a. Cell. Microbiol. 2005 7: 5361.
  • 37
    Ogura, Y., Inohara, N., Benito, A., Chen, F. F., Yamaoka, S. and Nunez, G., Nod2, a Nod1/Apaf-1 family member that is restricted to monocytes and activates NF-kappaB. J. Biol. Chem. 2001 276: 48124818.
  • 38
    Li, J., Moran, T., Swanson, E., Julian, C., Harris, J., Bonen, D. K., Hedl, M. et al., Regulation of IL-8 and IL-1beta expression in Crohn's disease associated NOD2/CARD15 mutations. Hum. Mol. Genet. 2004 13: 17151725.
  • 39
    Dinarello, C. A., Interleukin-1, interleukin-1 receptors and interleukin-1 receptor antagonist. Int. Rev. Immunol. 1998 16: 457499.
  • 40
    Wolfert, M. A., Murray, T. F., Boons, G. J. and Moore, J. N., The origin of the synergistic effect of muramyl dipeptide with endotoxin and peptidoglycan. J. Biol. Chem. 2002 277: 3917939186.
  • 41
    Hirschfeld, M., Weis, J. J., Toshchakov, V., Salkowski, C. A., Cody, M. J., Ward, D. C., Qureshi, N. et al., Signaling by toll-like receptor 2 and 4 agonists results in differential gene expression in murine macrophages. Infect. Immun. 2001 69: 14771482.
  • 42
    Grebenchtchikov, N., Van der Ven-Jongekrijg, J., Pesman, G. J., Geurts-Moespot, A., Van der Meer, J. W. and Sweep, F. C., Development of a sensitive ELISA for the quantification of human tumour necrosis factor-alpha using 4 polyclonal antibodies. Eur. Cytokine Netw. 2005 16: 215222.
  • 43
    Arya, M., Shergill, I. S., Williamson, M., Gommersall, L., Arya, N. and Patel, H. R., Basic principles of real-time quantitative PCR. Expert. Rev. Mol. Diagn. 2005 5: 209219.